Notice Number: NOT-AI-19-020
Key Dates
Release Date: December 18, 2018
Issued by
National Institute of Allergy and Infectious Diseases (NIAID)
National Cancer Institute (NCI)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Purpose
The purpose of this Notice is to alert potential applicants to a change in the expiration date for Funding Opportunity Announcement (FOA) PA-17-280 "In Vitro and Animal Model Studies on HBV/HIV Co-Infection (R01) . This FOA will expire on January 8, 2019 (earlier than previously published); the last date that NIAID, NCI and NIAAA will accept applications for PA-17-280 is January 7, 2019. After January 7, 2019 , applicants may apply to the new NIAID FOA, PAS-19-097 Research to Advance HBV Cure: HIV/HBV Co-Infection and HBV Mono-infection (R01 Clinical Trial Not Allowed) .
Part 1: Overview Information
Key Dates
Current Date:
Expiration Date: May 8, 2020
Revised Date:
Expiration Date: January 8, 2019
All other aspects of this FOA remain unchanged.
Inquiries
Please direct all inquiries to:
Chris Lambros, Ph.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-627-3093
Email: [email protected]
Elizabeth Read-Connole, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-6226
Email: [email protected]
Rebecca Liddell Huppi, Ph.D.
National Cancer Institute (NCI)
Telephone: 301-496-4995
Email: [email protected]
H. Joe Wang, Ph.D. (for basic biological-immunologic studies and tissue injury)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Telephone: 301-451-0747
Email: [email protected]